Antagonism of botulinum toxin type A-induced cleavage of SNAP-25 in rat cerebral synaptosome by toosendanin

FEBS Letters

Volumn 555, Issue 2, 2003, Pages 375-379

  Zhou, Jian Ying ^a   Wang, Zhong Feng ^a   Ren, Xiao Mei ^a   Tang, Mian Zhi ^a   Shi, Yu Liang ^a  

^a Chinese Academy of Sciences   (China)

Author keywords

Antibotulismic mechanism; Botulinum toxin type A; Synaptosomal associated protein of 25 kDa; Synaptosome; Toosendanin; Western blotting

Indexed keywords

BOTULINUM TOXIN A; IMMUNOGLOBULIN LIGHT CHAIN; SYNAPTOBREVIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNTAXIN; TOOSENDANIN; TOXIN; TRITERPENOID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BOTULISM; BRAIN; CONTROLLED STUDY; DISEASE RESISTANCE; DRUG ACTIVITY; DRUG EFFECT; ELECTROPHORESIS; INCUBATION TIME; MALE; MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SYNAPTOSOME; WESTERN BLOTTING;

EID: 0344872504     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(03)01291-2     Document Type: Article

References (34)

1. Simpson L.L. Annu. Rev. Pharmacol. Toxicol. 26:1986;427-453.
2. Burgen A.S.V., Dickend F., Zatman L.J. J. Physiol. 109:1949;10-24.
3. Lacy D.B., Tepp W., Cohen A.C., DasGupta B.R., Stevens R.C. Nat. Struct. Biol. 5:1998;898-902.
4. Swaminathan S., Eswaramoorthy S. Nat. Struct. Biol. 7:2000;693-699.
5. Montecucco C., Papini E., Schiavo G. FEBS Lett. 346:1994;92-98.
6. Schiavo G., Matteoli M., Montecucco C. Physiol. Rev. 80:2000;717-766.
7. Humeau Y., Doussau F., Grant N.J., Poulain B. Biochimie. 82:2000;427-446.
8. Adler M., Scovill J., Parker G., Lebeda F.J., Piotrowski J., Deshpande S.S. Toxicon. 33:1995;527-537.
9. Adler M., Macdonald D.A., Sellin L.C., Parker G.W. Toxicon. 34:1996;237-249.
10. Adler M., Dinterman R.E., Wannemacher R.W. Toxicon. 35:1997;1089-1100.
11. Adler M., Nicholson J.D., Hackley B.E. FEBS Lett. 429:1998;234-238.
12. Bakry N., Kamata Y., Simpson L.L. J. Pharmacol. Exp. Ther. 258:1991;830-836.
13. Kalandakanond S., Coffield J.A. J. Pharmacol. Exp. Ther. 296:2001;980-986.
14. Sheridan R.E. Toxicon. 34:1996;849-855.
15. Deshpande S.S., Sheridan R.E., Adler M. Toxicon. 33:1995;551-557.
16. Chang C.C., Hsie T.H., Chen S.F., Liang H.T. Acta Chim. Sin. 33:1975;35-47.
17. Shu G.X., Liang X.T. Acta Chim. Sin. 38:1980;196-198.
18. Wang Y.B., Wen Y.X. J. Tradit. Chin. Med. 262:1959;46-49.
19. Li P.Z., Zhou J., Miao W.Y., Ding F.H., Meng J.Y., Jia G.R., Li J.F., Ye H.J., He X.Y., Chen M.Y., Huang Z.M. Chin. Tradit. Herb. Drugs. 13:1982;28-30.
20. Shi Y.L., Xu K. Chin. Sci. Bull. 28:1983;885-887.
21. Li P.Z., Sun G.Z. Acta Physiol. Sin. 35:1983;480-483.
22. Shi Y.L., Hsu K. Jpn. J. Physiol. 33:1983;677-680.
23. Xu Y.F., Shi Y.L. Brain Res. 631:1993;46-50.
24. Hu Q., Huang F.S., Shi Y.L. Brain Res. 751:1997;47-53.
25. Wang Z.F., Shi Y.L. Neuroscience. 104:2001;41-47.
26. Wang Z.F., Shi Y.L. Neurosci. Lett. 303:2001;13-16.
27. Wang Z.F., Shi Y.L. Neurosci. Res. 40:2001;211-215.
28. McMahon Foran P., Dolly J.O., Verhage M., Wiegant V.M., Nicholls D.G. J. Biol. Chem. 267:1992;21338-21343.
29. Bradford M.M. Anal. Biochem. 72:1976;248-254.
30. von Mollard G.F., Südhof T.C., Jahn R. Nature. 349:1991;79-81.
31. Schiavo G., Shone C.C., Bennett M.K., Scheller R.H., Montecucco C. J. Biol. Chem. 270:1995;10566-10570.
32. Yamasaki S., Hu Y., Binz T., Kalkuhl A., Tamura T., Jahn R., Kandel E., Niemann H. Proc. Natl. Acad. Sci. USA. 91:1994;4688-4692.
33. Dolly J.O., Black J., Williams R.S., Melling J. Nature. 307:1984;457-460.
34. Agui T., Syuto B., Oguma K., Iida H., Kubo S. J. Biochem. (Tokyo). 94:1983;521-527.